41 related articles for article (PubMed ID: 31574377)
1. RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer.
Gong Z; Li J; Cang P; Jiang H; Liang J; Hou Y
Biomed Pharmacother; 2019 Dec; 120():109440. PubMed ID: 31574377
[TBL] [Abstract][Full Text] [Related]
2. RPL34-Divergent Transcript, a Novel Long NonCoding Ribonucleic Acid, Promotes Migration by Activating Epithelial-Mesenchymal Transition in Glioma.
Lu X; Zhang D
World Neurosurg; 2023 Nov; 179():e582-e592. PubMed ID: 37689361
[TBL] [Abstract][Full Text] [Related]
3. Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis.
Kang K; Wu J; Mao Y; Kai J; Chen S; Xiong F
J Coll Physicians Surg Pak; 2023 Sep; 33(9):964-971. PubMed ID: 37691355
[TBL] [Abstract][Full Text] [Related]
4. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.
Zhang J; Luo A; Huang F; Gong T; Liu Z
Cancer Lett; 2020 Jan; 469():390-398. PubMed ID: 31730904
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p.
Huang GM; Zang HL; Geng YX; Li YH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9408-9415. PubMed ID: 33015782
[TBL] [Abstract][Full Text] [Related]
6. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
Ji L; Fan X; Zhou F; Gu J; Deng X
J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
[TBL] [Abstract][Full Text] [Related]
7. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
[TBL] [Abstract][Full Text] [Related]
8. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract][Full Text] [Related]
9. Potential Candidate Genes for Therapeutic Targeting in Chronic Myeloid Leukemia: A Pilot Study.
Alsamman K; Alamri AM; Vatte C; Owaidah AY; Alhassan F; Mubarki R; El-Masry OS
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3077-3085. PubMed ID: 37774059
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications in esophageal cancer: An evolving biomarker.
Liu WJ; Zhao Y; Chen X; Miao ML; Zhang RQ
Front Genet; 2022; 13():1087479. PubMed ID: 36704345
[TBL] [Abstract][Full Text] [Related]
11. ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer.
Li F; Ma J; Yan C; Qi Y
Am J Transl Res; 2022; 14(11):8064-8084. PubMed ID: 36505280
[TBL] [Abstract][Full Text] [Related]
12. LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
Zhang H; Pan E; Zhang Y; Zhao C; Liu Q; Pu Y; Yin L
BMC Cancer; 2022 Sep; 22(1):1017. PubMed ID: 36162992
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Lamin B1 and the Corresponding Lamin B Receptor Leads to Changes in Heterochromatin State and Senescence Induction in Malignant Melanoma.
Lämmerhirt L; Kappelmann-Fenzl M; Fischer S; Pommer M; Zimmermann T; Kluge V; Matthies A; Kuphal S; Bosserhoff AK
Cells; 2022 Jul; 11(14):. PubMed ID: 35883595
[TBL] [Abstract][Full Text] [Related]
14. An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer.
Zhang Z; Luo Y; Zhang C; Wu P; Zhang G; Zeng Q; Wang L; Xue L; Yang Z; Zeng H; Zheng B; Tan F; Xue Q; Gao S; Sun N; He J
Cancer Cell Int; 2021 Dec; 21(1):691. PubMed ID: 34930244
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA.
Zhang D; Jiang H; Ye J; Gao M; Wang X; Lu E; Yang H; Wang L; Zhao S
J Cancer; 2021; 12(20):6189-6197. PubMed ID: 34539892
[No Abstract] [Full Text] [Related]
16. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
17. Preliminary screening and correlation analysis for lncRNAs related to radiosensitivity in melanoma cells by inhibiting glycolysis.
Wang Q; Huang C; Hu Y; Yan W; Gong L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):565-574. PubMed ID: 34275924
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
